JP MORGAN/CALL/ELI LILLY & CO/820/0.01/17.01.25 | Market Closed - Bid/Ask 03:39:48 27/06/2024 pm IST | After market 01:07:59 am | |||
| 1.4 EUR | +7.69% |
|
1.395 | -0.36% |
| Current month | +46.07% | ||
| 1 month | +51.16% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 27/24/27 | 1.4 | +7.69% |
| 25/24/25 | 1.3 | +2.36% |
| 24/24/24 | 1.27 | +0.79% |
| 21/24/21 | 1.26 | -3.08% |
| 20/24/20 | 1.3 | -1.52% |
Delayed Quote Börse Stuttgart
Last update June 27, 2024 at 03:39 pm IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | J.P. Morgan |
| WKN | JK27V6 |
| ISIN | DE000JK27V68 |
| Date issued | 08/02/2024 |
| Strike | 820 $ |
| Maturity | 17/01/2025 (204 Days) |
| Parity | 100 : 1 |
| Emission price | 0.48 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.4 € |
|---|---|
| Lowest since issue | 0.51 € |
| Delta | 0.73x |
| Omega | 4.471 |
| Premium | 7.07x |
| Gearing | 6.1x |
| Moneyness | 1.103 |
| Difference Strike | -87.3 $ |
| Difference Strike % | -10.65% |
| Spread | 0.01 € |
| Spread % | 0.72% |
| Theoretical value | 1.385 |
| Implied Volatility | 33.47 % |
| Total Loss Probability | 35.27 % |
| Intrinsic value | 0.7875 |
| Present value | 0.5975 |
| Break even | 968.23 € |
| Theta | -0.02x |
| Vega | 0.02x |
| Rho | 0.03x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
901.3
USD
Average target price
860.5
USD
Spread / Average Target
-4.52%
- Stock Market
- Warrants
- Warrant
